Treatment resistant psychosis in adolescents
Clozapine, an antipsychotic medication licensed for treatment resistant psychosis, is under prescribed and delays in getting effective treatment results in worse outcomes. The aims of the project are to identify a) the prevalence of treatment resistant psychosis in the adolescent population in South London and Maudsley NHS Foundation Trust., b) current medication regime that patients are prescribed, c) potential barriers to treatment with clozapine.